|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127,000.00 KRW | -1.09% |
|
-7.37% | +20.15% |
| 05-27 | HEALTH ROUNDS-Veracyte genomic test identifies breast cancer patients who can skip chemo | RE |
| 05-15 | ORION Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 140,300 | 146,000 | 143,600 |
| Spread/Res. | -9.48% | -13.01% | -11.56% |
| Spread/Supp. | +1.76% | +15.56% | +5.22% |
| Support | 124,800 | 109,900 | 120,700 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A271560 Stock
- Charts ORION Corp.
Select your edition
All financial news and data tailored to specific country editions
